• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过KAP1/TRIM28磷酸化开关从潜伏状态释放人巨细胞病毒。

Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch.

作者信息

Rauwel Benjamin, Jang Suk Min, Cassano Marco, Kapopoulou Adamandia, Barde Isabelle, Trono Didier

机构信息

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

出版信息

Elife. 2015 Apr 7;4:e06068. doi: 10.7554/eLife.06068.

DOI:10.7554/eLife.06068
PMID:25846574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4384640/
Abstract

Human cytomegalovirus (HCMV) is a highly prevalent pathogen that induces life-long infections notably through the establishment of latency in hematopoietic stem cells (HSC). Bouts of reactivation are normally controlled by the immune system, but can be fatal in immuno-compromised individuals such as organ transplant recipients. Here, we reveal that HCMV latency in human CD34(+) HSC reflects the recruitment on the viral genome of KAP1, a master co-repressor, together with HP1 and the SETDB1 histone methyltransferase, which results in transcriptional silencing. During lytic infection, KAP1 is still associated with the viral genome, but its heterochromatin-inducing activity is suppressed by mTOR-mediated phosphorylation. Correspondingly, HCMV can be forced out of latency by KAP1 knockdown or pharmacological induction of KAP1 phosphorylation, and this process can be potentiated by activating NFkB with TNF-α. These results suggest new approaches both to curtail CMV infection and to purge the virus from organ transplants.

摘要

人巨细胞病毒(HCMV)是一种高度流行的病原体,主要通过在造血干细胞(HSC)中建立潜伏感染而引发终身感染。病毒再激活通常受免疫系统控制,但在免疫功能低下的个体(如器官移植受者)中可能是致命的。在此,我们发现HCMV在人CD34(+) HSC中的潜伏反映了主共抑制因子KAP1、HP1和SETDB1组蛋白甲基转移酶在病毒基因组上的募集,这导致转录沉默。在裂解感染期间,KAP1仍与病毒基因组相关,但mTOR介导的磷酸化抑制了其异染色质诱导活性。相应地,通过敲低KAP1或药理学诱导KAP1磷酸化可使HCMV脱离潜伏状态,并且用TNF-α激活NFkB可增强这一过程。这些结果提示了减少CMV感染以及从器官移植中清除病毒的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/bef065c6bb2b/elife06068f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/def1829f3a2c/elife06068f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/57524defb9a9/elife06068fs001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/c2334a371e87/elife06068fs002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/0fa82ec60679/elife06068fs003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/be9d48cafa12/elife06068fs004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2944bdc3e00f/elife06068f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/7f028f7b16eb/elife06068fs005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/dd596699bd11/elife06068f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/059506286941/elife06068fs006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/95ed0c1550d4/elife06068f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cfb2277c2f1d/elife06068fs007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/1772a2633416/elife06068fs008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cac73d871e03/elife06068f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/200f08409919/elife06068fs009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2e242396b4ce/elife06068f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/00f5864269b9/elife06068fs010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/ba797d837cb4/elife06068fs011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6b5a7c562337/elife06068fs012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/53020e89efc2/elife06068fs013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/8e7e930eb6ba/elife06068fs014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/8a8a2eed72af/elife06068fs015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6357f27bb28b/elife06068f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/9792ecfaae12/elife06068fs016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2e1b8c2733e7/elife06068fs017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/abd8799fcf65/elife06068f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/462a17c8d278/elife06068fs018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cd17ed5c83ed/elife06068fs019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/774377b5173f/elife06068fs020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/9d27f77063a9/elife06068f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/c7a2e28628e8/elife06068f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/38adead2560f/elife06068f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6a83a477272b/elife06068f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/bef065c6bb2b/elife06068f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/def1829f3a2c/elife06068f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/57524defb9a9/elife06068fs001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/c2334a371e87/elife06068fs002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/0fa82ec60679/elife06068fs003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/be9d48cafa12/elife06068fs004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2944bdc3e00f/elife06068f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/7f028f7b16eb/elife06068fs005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/dd596699bd11/elife06068f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/059506286941/elife06068fs006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/95ed0c1550d4/elife06068f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cfb2277c2f1d/elife06068fs007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/1772a2633416/elife06068fs008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cac73d871e03/elife06068f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/200f08409919/elife06068fs009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2e242396b4ce/elife06068f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/00f5864269b9/elife06068fs010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/ba797d837cb4/elife06068fs011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6b5a7c562337/elife06068fs012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/53020e89efc2/elife06068fs013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/8e7e930eb6ba/elife06068fs014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/8a8a2eed72af/elife06068fs015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6357f27bb28b/elife06068f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/9792ecfaae12/elife06068fs016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/2e1b8c2733e7/elife06068fs017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/abd8799fcf65/elife06068f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/462a17c8d278/elife06068fs018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/cd17ed5c83ed/elife06068fs019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/774377b5173f/elife06068fs020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/9d27f77063a9/elife06068f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/c7a2e28628e8/elife06068f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/38adead2560f/elife06068f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/6a83a477272b/elife06068f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4687/4384640/bef065c6bb2b/elife06068f013.jpg

相似文献

1
Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch.通过KAP1/TRIM28磷酸化开关从潜伏状态释放人巨细胞病毒。
Elife. 2015 Apr 7;4:e06068. doi: 10.7554/eLife.06068.
2
Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34 Hematopoietic Progenitor Cells and Humanized NSG Mice.人巨细胞病毒 US28 配体结合活性是潜伏在 CD34 造血祖细胞和人源化 NSG 小鼠中所必需的。
mBio. 2019 Aug 20;10(4):e01889-19. doi: 10.1128/mBio.01889-19.
3
Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34 Human Progenitor Cells.人巨细胞病毒需要表皮生长因子受体信号传导才能进入并启动在CD34人祖细胞中建立潜伏感染的早期步骤。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.01206-16. Print 2017 Mar 1.
4
The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation.ATM 底物 KAP1 控制异染色质中的 DNA 修复:HP1 蛋白和丝氨酸 473/824 磷酸化的调节。
Mol Cancer Res. 2012 Mar;10(3):401-14. doi: 10.1158/1541-7786.MCR-11-0134. Epub 2011 Dec 28.
5
Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency.肿瘤坏死因子-α在潜伏状态建立后的转录后诱导人巨细胞病毒的重新激活,而不依赖于髓样细胞分化。
mBio. 2018 Sep 11;9(5):e01560-18. doi: 10.1128/mBio.01560-18.
6
Human cytomegalovirus infection induces L1 expression through UL38-dependent mTOR-KAP1 pathway.人巨细胞病毒感染通过UL38依赖的mTOR-KAP1途径诱导L1表达。
PLoS One. 2025 Apr 23;20(4):e0320512. doi: 10.1371/journal.pone.0320512. eCollection 2025.
7
Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations.髓样细胞系模拟了人类巨细胞病毒实验潜伏期的某些方面,但不是全部,这些方面是在原代 CD34+ 细胞群体中定义的。
J Virol. 2013 Sep;87(17):9802-12. doi: 10.1128/JVI.01436-13. Epub 2013 Jul 3.
8
Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.潜伏相关表达的人巨细胞病毒 US28 减轻细胞信号通路以维持潜伏感染。
mBio. 2017 Dec 5;8(6):e01754-17. doi: 10.1128/mBio.01754-17.
9
KAP1 controls endogenous retroviruses in embryonic stem cells.KAP1 控制胚胎干细胞中的内源性逆转录病毒。
Nature. 2010 Jan 14;463(7278):237-40. doi: 10.1038/nature08674.
10
CD34 Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.CD34 造血祖细胞亚群表现出维持人类巨细胞病毒潜伏和持续感染的不同能力。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.02105-20.

引用本文的文献

1
Insights into the protein domains of C-VI TRIM subfamily in viral infection.病毒感染中C-VI TRIM亚家族蛋白结构域的见解
Front Cell Infect Microbiol. 2025 May 12;15:1573422. doi: 10.3389/fcimb.2025.1573422. eCollection 2025.
2
Human cytomegalovirus infection induces L1 expression through UL38-dependent mTOR-KAP1 pathway.人巨细胞病毒感染通过UL38依赖的mTOR-KAP1途径诱导L1表达。
PLoS One. 2025 Apr 23;20(4):e0320512. doi: 10.1371/journal.pone.0320512. eCollection 2025.
3
TRIM Proteins: Key Regulators of Immunity to Herpesvirus Infection.

本文引用的文献

1
Rapamycin does not inhibit human cytomegalovirus reactivation from dendritic cells in vitro.雷帕霉素不能抑制体外树突状细胞中的人巨细胞病毒激活。
J Gen Virol. 2014 Oct;95(Pt 10):2260-2266. doi: 10.1099/vir.0.066332-0. Epub 2014 Jul 1.
2
Evolutionally dynamic L1 regulation in embryonic stem cells.胚胎干细胞中具有进化动态性的L1调控
Genes Dev. 2014 Jul 1;28(13):1397-409. doi: 10.1101/gad.241661.114. Epub 2014 Jun 17.
3
Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements.TRIM28与DNA甲基化在控制人类内源性逆转录元件中的相互作用。
TRIM 蛋白:疱疹病毒感染免疫的关键调节剂。
Viruses. 2024 Nov 6;16(11):1738. doi: 10.3390/v16111738.
4
The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.HUSH 表观遗传抑制复合物沉默 PML 核体相关 HSV-1 静止基因组。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2412258121. doi: 10.1073/pnas.2412258121. Epub 2024 Nov 26.
5
The Immune Modulatory Role of TIF1 Proteins.TIF1 蛋白的免疫调节作用。
Adv Exp Med Biol. 2024;1466:89-99. doi: 10.1007/978-981-97-7288-9_6.
6
XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.XAF1 通过组装一个由 ZNF313 介导的降解复合物来拮抗 TRIM28 的活性,从而抑制肿瘤恶性。
Mol Biomed. 2024 Nov 13;5(1):58. doi: 10.1186/s43556-024-00224-9.
7
An epigenetic human cytomegalovirus infection score predicts viremia risk in seropositive lung transplant recipients.一种表观遗传人类巨细胞病毒感染评分可预测血清阳性肺移植受者的病毒血症风险。
Epigenetics. 2024 Dec;19(1):2408843. doi: 10.1080/15592294.2024.2408843. Epub 2024 Oct 3.
8
Human cytomegalovirus harnesses host L1 retrotransposon for efficient replication.人巨细胞病毒利用宿主 L1 反转录转座子进行高效复制。
Nat Commun. 2024 Sep 2;15(1):7640. doi: 10.1038/s41467-024-51961-y.
9
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.人疱疹病毒再激活及其在新型冠状病毒肺炎感染后急性后遗症发病机制中的潜在作用。
Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29.
10
KAP1/TRIM28 - antiviral and proviral protagonist of herpesvirus biology.KAP1/TRIM28——疱疹病毒生物学中的抗病毒和前病毒主角。
Trends Microbiol. 2024 Dec;32(12):1179-1189. doi: 10.1016/j.tim.2024.05.007. Epub 2024 Jun 12.
Genome Res. 2014 Aug;24(8):1260-70. doi: 10.1101/gr.172833.114. Epub 2014 May 30.
4
A unique SUMO-2-interacting motif within LANA is essential for KSHV latency.LANA 内一个独特的与 SUMO-2 相互作用的基序对卡波西肉瘤相关疱疹病毒潜伏至关重要。
PLoS Pathog. 2013;9(11):e1003750. doi: 10.1371/journal.ppat.1003750. Epub 2013 Nov 21.
5
Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.从健康的血清阳性供体中分离出的循环树突状细胞是体内人类巨细胞病毒重新激活的部位。
J Virol. 2013 Oct;87(19):10660-7. doi: 10.1128/JVI.01539-13. Epub 2013 Jul 24.
6
Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection.潜伏性人巨细胞病毒感染期间 MRP1 药物转运蛋白的潜伏相关降解。
Science. 2013 Apr 12;340(6129):199-202. doi: 10.1126/science.1235047.
7
A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy.一个 KRAB/KAP1-miRNA 级联反应通过对细胞自噬的阶段特异性控制来调节红细胞生成。
Science. 2013 Apr 19;340(6130):350-3. doi: 10.1126/science.1232398. Epub 2013 Mar 14.
8
A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.一种新型选择性 LSD1/KDM1A 抑制剂通过表观遗传阻断单纯疱疹病毒从潜伏状态向裂解复制和再激活的转变。
mBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12.
9
Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis.接受 mTOR 抑制剂为基础的免疫抑制治疗的患者中,巨细胞病毒预防是否可以省略?一项系统评价和荟萃分析。
Transplantation. 2012 Dec 27;94(12):1208-17. doi: 10.1097/TP.0b013e3182708e56.
10
Decoding human cytomegalovirus.解码人类巨细胞病毒。
Science. 2012 Nov 23;338(6110):1088-93. doi: 10.1126/science.1227919.